Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

Tanja Fensa University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands;b Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

https://orcid.org/0000-0003-3995-447X View further author information

Guiling Zhouc Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsView further author information

Maarten J. Postmaa University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands;b Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;d University of Groningen, University Medical Center Groningen, Institute of Science in Healthy Aging & healthcaRE (SHARE), Groningen, The Netherlands;e Faculty of Economics & Business, Department of Economics, Econometrics & Finance, University of Groningen, Groningen, The Netherlands

https://orcid.org/0000-0002-6306-3653 View further author information

Eugène P. van Puijenbroeka University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands;f Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, MH, The Netherlands;g Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

https://orcid.org/0000-0002-2236-1398 View further author information

Job F.M. van Bovenc Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;h University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands;i Medication Adherence Expertise Center of the Northern Netherlands (MAECON), Groningen, The NetherlandsCorrespondence[email protected]

https://orcid.org/0000-0003-2368-2262 View further author information

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

Citations (3)

Read on this site (2)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date